Archive for Jeff Wilder

Helen of Troy (NASDAQ:HELE) had its price target increased by Bank of America from $170.00 to $175.00 in a research report report published on Wednesday morning, BenzingaRatingsTable reports. Bank of America currently has a buy rating on the stock. Several other research analysts have also issued reports on HELE. ValuEngine lowered shares of Helen of […]

Zacks Investment Research cut shares of Livent (NYSE:LTHM) from a hold rating to a sell rating in a report published on Thursday, Zacks.com reports. According to Zacks, “Livent Corporation produces and distributes lithium chemicals. The Company offers lithium chemicals for applications in batteries, agrochemicals, aerospace alloys, greases, pharmaceuticals, polymers, and various industrial applications. Livent Corporation […]

ValuEngine lowered shares of Methode Electronics (NYSE:MEI) from a sell rating to a strong sell rating in a research report sent to investors on Thursday, ValuEngine reports. A number of other equities research analysts have also weighed in on MEI. TheStreet raised Methode Electronics from a c+ rating to a b rating in a research […]

Guggenheim began coverage on shares of New York Times (NYSE:NYT) in a research note published on Wednesday morning, BenzingaRatingsTable reports. The firm issued a neutral rating and a $27.50 price objective on the stock. Several other analysts have also recently issued reports on NYT. Zacks Investment Research upgraded New York Times from a sell rating […]

Varex Imaging Corp (NASDAQ:VREX) saw a large decrease in short interest during the month of September. As of September 30th, there was short interest totalling 778,500 shares, a decrease of 15.2% from the August 30th total of 918,500 shares. Currently, 2.0% of the company’s stock are short sold. Based on an average daily trading volume, […]

Marvell Technology Group (NASDAQ:MRVL) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Friday, Zacks.com reports. They presently have a $25.00 target price on the semiconductor company’s stock. Zacks Investment Research‘s price objective would suggest a potential upside of 3.99% from the company’s current price. […]

Domino’s Pizza (NYSE:DPZ) had its price objective upped by JPMorgan Chase & Co. from $265.00 to $275.00 in a research report report published on Wednesday, BenzingaRatingsTable reports. JPMorgan Chase & Co. currently has an overweight rating on the restaurant operator’s stock. Several other equities analysts have also recently weighed in on DPZ. Cowen reissued an […]

Avalara Inc (NYSE:AVLR) saw a large growth in short interest in the month of September. As of September 30th, there was short interest totalling 3,120,000 shares, a growth of 19.5% from the August 30th total of 2,610,000 shares. Based on an average trading volume of 1,110,000 shares, the short-interest ratio is presently 2.8 days. Currently, […]

Zacks Investment Research lowered shares of Kontoor Brands (NYSE:KTB) from a buy rating to a hold rating in a research note issued to investors on Wednesday, Zacks.com reports. According to Zacks, “Kontoor Brands Inc. is an apparel company. It designs, manufactures and distributes products. The company’s brand consists of Wrangler(R), Lee(R) and Rock & Republic(R). […]

Elixir (CURRENCY:ELIX) traded 0.8% higher against the U.S. dollar during the twenty-four hour period ending at 9:00 AM ET on October 13th. During the last seven days, Elixir has traded 30.1% lower against the U.S. dollar. Elixir has a market capitalization of $29,812.00 and approximately $17.00 worth of Elixir was traded on exchanges in the […]

Welch & Forbes LLC acquired a new stake in Genuine Parts (NYSE:GPC) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,638 shares of the specialty retailer’s stock, valued at approximately $263,000. Several other institutional investors and hedge […]

Zacks Investment Research cut shares of AnaptysBio (NASDAQ:ANAB) from a hold rating to a sell rating in a research report sent to investors on Wednesday, Zacks.com reports. According to Zacks, “AnaptysBio, Inc. is a biotechnology company. It involved in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology primarily in the Unites states. […]